Komlossy Law, P.A. is investigating the Board of Directors of Astex Pharmaceuticals, Inc. (“Astex”) or the “Company”) (NASDAQ:ASTX) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to Otsuka Pharmaceutical ("Otsuka") in a transaction valued at approximately $886 million. Pursuant to the terms of the proposed transaction, Astex shareholders are to receive $8.50 for each share of the Company.
The investigation involves whether the Board of Directors of Astex breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, and whether the transaction is fair to shareholders with respect to price, process and disclosure of all material information.
If you own Astex stock and wish to obtain additional information about your rights as a shareholder, or if you have information about the above investigation, please contact Emily C. Komlossy, Esq. via email at email@example.com or by telephone toll free at (855) 858-1233.
Komlossy Law, P.A. represents shareholders in complex litigation, including class action and derivative litigation. Komlossy Law, P.A. may co-counsel with another firm, or refer a case to another firm. More information is available through the firm’s website, www.komlossylaw.com, and upon request. Emily C. Komlossy is the attorney responsible for the content of this release.
|Emily C. Komlossy, Esq.|
|Komlossy Law, P.A.|
|2131 Hollywood Boulevard, Suite 408|
|Hollywood, FL 33020|
Attorney Advertisement. Past results do not guarantee or predict a similar outcome with respect to any future matter.
Komlossy Law, P.A.
Emily C. Komlossy, Esq., 855-858-1233
|Law Firm Brower Piven Announces Investigation of Astex Pharmaceuticals, Inc. Proposed Acquisition ()|
|SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Astex Pharmaceuticals, Inc. (2013/9/6)|
|Newman Ferrara LLP Announces Investigation of Astex Pharmaceutics, Inc. (2013/9/5)|
|Finkelstein Thompson LLP Announces Investigation of Astex Pharmaceuticals, Inc. Buyout ()|
|Rigrodsky & Long, P.A. Announces Investigation Of Astex Pharmaceuticals, Inc. Buyout (2013/9/5)|
|Law Offices of Howard G. Smith Announces Investigation of Astex Pharmaceuticals, Inc. (2013/9/5)|
|Harwood Feffer LLP Announces Investigation of Astex Pharmaceuticals Inc. ()|
|Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Astex Pharmaceuticals Proposed Acquisition by Otsuka Holdings (2013/9/5)|
|Law Firm Brower Piven Announces Investigation of Onyx Pharmaceuticals, Inc. Proposed Buyout ()|
|Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Intercept Pharmaceuticals, Inc. (2014/1/14)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.